chrisvoncsefalvay/vaers-outcomes huggingface dataset:
no adverse reaction, pt was given the wrong vaccine pt was given PPV 23 and pt was supposed to be given PCV 13
feeling dizzy; Feeling weak; sore arm  at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feeling dizzy), ASTHENIA (Feeling weak) and VACCINATION SITE PAIN (sore arm  at the injection site) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (sore arm  at the injection site). On 27-Apr-2021, the patient experienced DIZZINESS (feeling dizzy) and ASTHENIA (Feeling weak). At the time of the report, DIZZINESS (feeling dizzy), ASTHENIA (Feeling weak) and VACCINATION SITE PAIN (sore arm  at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not provided Treatment medication were not reported.   This case was linked to MOD-2021-373440 (Patient Link).
Patient had tingling at injection site left side, hand, leg, and face immediately, followed by 15-20 later dizziness, pass out, pounding heart, extremity weakness (loss of function), nauseous, increased heart rate, lowered blood pressure- patient went to ED for monitoring of blood pressure, heart rate, oxygen. Took around 90 minutes to start to normalize. Patient was then able to walk and returned home.  30 hours later was still experiencing increased heart rate and low blood oxygenation. Patient then was returning to normal.
kept going back and wanting to go to sleep; Fever; weak; chills were real bad, it made him shake; pulse has been high ever since the shot; has the thing you put on finger to read oxygen, it was 92 one time; arm sore; This is a spontaneous report from a contactable consumer(patient). A 76-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration, administered in Deltoid Left on 11Feb2021 (at12:00) (Batch/Lot Number: EN9581) as Dose Number Unknown, 0.3ML Single for Covid-19 immunization. Medical history included Gastroesophageal reflux disease, Blood cholesterol; Only takes acid reflux and cholesterol medicine and Covid-19 From an unknown date and unknown if ongoing. The patients' concomitant medications were not reported. The patient experienced Arm sore on 11Feb2021, Fever on 12Feb2021 at 05:48, Chills were real bad, it made him shake, Pulse has been high ever since the shot and Has the thing you put on finger to read oxygen, it was 92 one time, weak on 12Feb2021, Kept going back and wanting to go to sleep on an unspecified date. The patient underwent lab tests and procedures which included body temperature: 101 on 12Feb2021, Body temperature: 101.6 on 12Feb2021, Body temperature: 100.3 on 12Feb2021, Heart rate: high on 12Feb2021, Oxygen saturation: 96-98 on 12Feb2021, Oxygen saturation: was like 92 one time on 12Feb2021. There was no Assessment. A query was raised to confirm Patient's last name and then the response was received After listening to the recording. The outcome of event for Arm, Chills were real bad, it made him shake, Pulse has been high ever since the shot and Has the thing you put on finger to read oxygen, it was 92 one time, and Kept going back and wanting to go to sleep sore was unknown. The outcome for event Fever and weak was resolving.   Follow-up attempts are completed. No further information is expected.
Lymphadenopathy; Under arm swelling and pain; under arm swelling and pain; This is a spontaneous report received from a non-contactable consumer.   A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had a shot in the left arm, on "Monday" experienced lymphadenopathy, under arm swelling and pain 12/10. Outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a registered nurse refers to a 9 years old patient. The patient was vaccinated with VARIVAX (dose, duration and lot number not provided) on unknown dates "last month", in June 2012. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patients had injection site swelling as big as baseball. The patient had sought medical attention via calling the office and was given BENADRYL and ice for the adverse event. None laboratory diagnostics studies were performed. The outcome the patient's adverse events was unknown. This is one of several reports received from the same source. Additional information is not expected.
Localized redness at the injection site; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on unspecified date at a single dose for vaccination; anthrax vaccine, smallpox vaccine (four times), yellow fever vaccine, cholera vaccine, plague vaccine, hepatitis a vaccine;hepatitis b vaccine and influenza vaccine, all via an unspecified routes of administration on unspecified dates at unknown doses for vaccination. The patient's medical history and concomitant medications were not reported. The patient had been vaccinated for about everything including anthrax, smallpox (four times), yellow fever, cholera, plague, pneumonia, hep A and B, and annual flu. The patient had never had any significant reaction other than localized redness at the injection site. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch cannot be obtained. No further information is expected.
patient  came in on 9/1 complaining that his arm is still sore everytime he raise his hand or trying to lift something. His arm can't  generate any power. He got his covid dose on 08/15/2021
Peripheral neuropathic pain/nerve pain in feet; Swelling of wrists; wrist pain/pain in wrists; Weakness/weak for about a day; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Peripheral neuropathic pain/nerve pain in feet), ASTHENIA (Weakness/weak for about a day), JOINT SWELLING (Swelling of wrists) and ARTHRALGIA (wrist pain/pain in wrists) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Previously administered products included for COVID-19 vaccination: PFIZER BIONTECH COVID-19 Vaccine (1st dose (1 in 1 Once), Route Intramuscular) on 21-Jan-2021, PFIZER BIONTECH COVID-19 Vaccine (2nd dose (1 in 1 Once), Route Intramuscular) on 15-Feb-2021, PFIZER BIONTECH COVID-19 Vaccine (3rd dose (1 in 1 Once) and Route Intramuscular) on 19-Aug-2021. Past adverse reactions to the above products included Vaccination site pain with PFIZER BIONTECH COVID-19 Vaccine, PFIZER BIONTECH COVID-19 Vaccine and PFIZER BIONTECH COVID-19 Vaccine. Concurrent medical conditions included Rheumatoid arthritis (Moderate to Severe).   On 19-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) First dose. In 2022, the patient experienced ASTHENIA (Weakness/weak for about a day). On an unknown date, the patient experienced NEURALGIA (Peripheral neuropathic pain/nerve pain in feet), JOINT SWELLING (Swelling of wrists) and ARTHRALGIA (wrist pain/pain in wrists). In 2022, ASTHENIA (Weakness/weak for about a day) had resolved. At the time of the report, NEURALGIA (Peripheral neuropathic pain/nerve pain in feet), JOINT SWELLING (Swelling of wrists) and ARTHRALGIA (wrist pain/pain in wrists) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient had swelling and pain in wrists. She had nerve pain in feet. In 2022, following the Moderna Covid-19 Vaccine she was weak for about a day. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporters Causality for rinvoq(upadacitinib) with response to all the events were not provided. Action taken with the Co-suspect vaccine was unknown.  No treatment details were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Reporter did not allow further contact
Pt arrived to post vaccination having not eaten yet this morning. Per the Pt wife, Pt has white coat syndrome and get very anxious when in clinical settings. Pt almost fell while walking up the stairs to the bleacher as he was dizzy and diaphoretic. Aid was called and took over care of PT at 1025. EMT released Pt with wife at 1029 as he was back to baseline. Pt finished observation time and wife drove Pt home.  Vitals at 1025 VItals: Bp 120/70 HR 64 RR 16 O2 99% on RA Pt is not a diabetic no BG was taken.
PAIN IN WHOLE RIGHT ARM AND BOTH LEGS; PAIN AT INJECTION SITE; FATIGUE; PAIN IN LEFT HIP; SHOOTING PAIN IN HEAD; SWELLING OF BOTH LEGS; PAIN OVER EYES; PAIN IN BRIDGE AND SIDE OF NOSE; STOMACH ACHE; NAUSEA; SEVERE HEADACHE; INSOMNIA; BLEEDING AT INJECTION SITE; This spontaneous report received from a patient concerned a 74 year old female. The patient's height, and weight were not reported. The patient's past medical history included superficial blood clot, and concurrent conditions included no alcohol user, and non smoker, and other pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 17/JUN/2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On 08-APR-2021, the subject experienced insomnia. On 08-APR-2021, the subject experienced bleeding at injection site. On 11-APR-2021, the subject experienced severe headache. On 11-APR-2021, the subject experienced nausea. On 11-APR-2021, the subject experienced stomach ache. On 15-APR-2021, the subject experienced pain at injection site. On 15-APR-2021, the subject experienced fatigue. On 15-APR-2021, the subject experienced pain in left hip. On 15-APR-2021, the subject experienced pain in whole right arm and both legs. On 15-APR-2021, the subject experienced shooting pain in head. On 15-APR-2021, the subject experienced swelling of both legs. On 15-APR-2021, the subject experienced pain over eyes. On 15-APR-2021, the subject experienced pain in bridge and side of nose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, and stomach ache on 11-APR-2021, insomnia on 09-APR-2021, and bleeding at injection site on 08-APR-2021, recovered with sequelae from severe headache on 11-APR-2021, and had not recovered from pain at injection site, fatigue, pain in left hip, shooting pain in head, pain over eyes, pain in bridge and side of nose, pain in whole right arm and both legs, and swelling of both legs. This report was non-serious.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: pt sat down after receiving vaccine and felt faint within the next minute, slouched over in the chair and woke up on his back on the floor. pharmacist reported pt was sweating but alert immediately after this incident. pharmacist assisted pt and pt ambulated into clinic with assistance and was supine for 10 minutes and sitting for 10 additional minutes. BP 118/76, pulse 79, spo2 98% and heart rhythm regular. pt ambulated out of clinic without problems, all symptoms resolved.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 12-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The pharmacist reported about the administration of expired moderna vaccine that was given as booster shot to patient. The vaccines was stored in freezer, which was taken out one to two vials and place in fridge each day as needed.  No treatment was given on the patient.
The pt developed mild varicella; 6-8 spots. Symptomatic treatment.
suspected vaccination failure; had the shingles and after I got the shot they came back with a vengeance; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  The patient's past medical history included shingles (had shingles).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient had the shingles and after he/she got the shot, shingles came back with a vengeance This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided
I RECEIVED THE VAX ON APRIL 16TH.  I FELT FEVERISH AND PUNY THE NEXT 48 HOURS.  I ALSO RECEIVED A TDAP THE SAME DAY IN THE SAME ARM WHICH LEFT MY SHOULDER SORE FOR 3 DAYS.  A LYMPHNODE ABOVE MY COLLARBONE ALSO SWELLED FOR THE NEXT DAY AND A HALF AFTER RECEIVING THE VAX.  ALL SYMPTOMS SEEMED TO THEN GO AWAY.  ON APRIL 26 I NOTICED THE INJECTION SITE OF THE VARICELLA VAX WAS RED AND PUFFY WITH ANOTHER PUFFY SPOT RIGHT NEXT TO IT.  THEY LOOKED AND FELT ALMOST LIKE A HIVE - WARM TO THE TOUCH AND SOMEWHAT FIRM AND SORE.  THE SPOTS GOT WORSE ON THE 27TH OF APRIL AND ARE STILL PRESENT TODAY, THE 28TH.  THE AREA OF THE REDNESS SITE IS LARGER THAN AN EGG AROUND.  I HAVE NOT ADMINISTERED ANY TREATMENT YET AND I WILL BE CALLING MY DOCTOR.  I HAVE BEEN EXPOSED TO CHICKENPOX AS A CHILD AND NEVER GOT IT.  I WAS TESTED FOR VARICELLA IMMUNITY LAST YEAR AND I WAS NOT IMMUNE.
After the 15 minute  post shot waiting period patient said  he felt "confused" with clammy hands.  He sat in the chair and was slow to talk.  I asked him if he was diabetic, and he responded that he was, but he never feels this way and had eaten before coming in.  After talking a while longer, I was going to ask him if he'd like us to check his sugar, he asked me if we had a blood pressure cuff.  I said we did, but he wanted to use the machine in front of the store because he felt well enough to get up and wanted to walk.   I walked to the machine with him.  He sat and answered the many questions tapping on screen with no issues at all.  The confusion was not evident.  The maching reported 111/68 or very close, with a pulse of 48.  He said, "that's the issue, my pulse is down.  I need to walk around." I said he could stay back at the pharmacy where we could see him, or we could call someone for him.  He said staying back here would not help his pulse. I told him there was no hurry, he'd been here for his 15 minutes, but we could keep an eye on him or help him and call whatever he needed.  He said no, he'd be fine, he just needed to walk around.  He now had  pressure in his head, not really a headache just pressure, he said it was all related to his pulse. He said if he needed help later he could always go to an Urgent Care, I offered again to call anywhere for him or call for assistance, he was not interested.
Heart arrhythmia (fluttering); I lost consciousness; This is a spontaneous report from a non-contactable consumer reporting for himself  A 56-year-old male patient received second dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8731) on 17Apr2021 at single dose via an unspecified route of administration  for COVID-19 immunization. The patient did not have relevant medical history. Concomitant medications were not reported. The patient received first dose of BNT162B2 (lot number: ER8730) on 27Mar2021 on arm left. On an unspecified date after vaccination the patient reported he had  lost consciousness in the morning right after exercise while experiencing arrhythmia. No treatment received for the events. At the time of the reporting the patient had not yet recovered from the events.   No follow-up attempts are possible. No further information is expected.
Blisters and erythematous, patch on the injection site. Left thigh where VAQTA (Hep B) was given.
Very achy noints, headache, fever 100.5.  Lasted only day after.  Fever broke evening of 01/26/2021 & body aches & headache went away.
Night chills all night. Had 106.0 temperature. Dr.s  nurse told me to take two Tylenols and if my temperature did not go down to go to ER.. It did after a couple hours. Despite being a little tired I was ok.
Flu like symptom 11/23/1999 very fatigue, loss of appetite, headache muscle ache.
Redness, itching, swelling, and pain at injection site Present first few days after injection but then went away; 1 week later on 4/12 these symptoms returned greater than before
Initially soreness at the injection site. That went away after a few days. On the evening of day 8 the soreness returned. There is also a small hard red bump much like a bug bite.
Initial report received on 16 April 2010 from a health care professional. A 4-year-old male patient had received on 24 September 2009 a fourth intramuscular dose of DAPTACEL (lot number C3157AA), and a third intramuscular dose of IPOL (lot number D0052-2). The lot number for IPOL is not a valid Sanofi pasteur lot number for this product. The patient denied any concurrent illnesses, but has medical history of allergy to eggs, wheat, soy, corn, beef, shrimp, and milk products. Patient denied use of any concomitant medications, and had not experience any adverse events with prior vaccinations. Within minutes of receiving the vaccinations on 24 September 2009, the patient developed generalized hives and wheezing. He was evaluated by a physician and treated with nebulizer treatments (trade name not provided) and Benadryl. It was not reported whether the patient had recovered or not. Documents held by sender: None
administered with expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  Vial was initially stored in the refrigerator on 28-Mar-2022. Vial did not undergo any temperature excursions.  No treatment information was provided by the reporter.
States noticed pain in L deltoid (works out with weights as is police officer) day after shot. Resumed weight workouts. On approx 12/24/10 noticed muscle spasms & twitching. Denies swelling of extremities. C/o burning pain in arm & now tightening of arm shoulder muscle that she feels maybe related to shot.
After her 1st anthrax vaccine, pt reports a moderate local reaction (redness, swelling, itching, warmth, and tenderness extending about 3-4" surrounding anthrax vaccine site; small subcutaneous nodule for about 2 weeks; no functional limitations and symptoms resolved after about 4 days). After 2nd anthrax vaccine, pt noted a similar reaction on post-vaccine day 1 (11/8). She self treated with OTC analgesics and antihistamines. On post-vaccine day 2 the affected area extended from just below her left shoulder to her elbow. She self treated with OTC analgesics and BENADRYL, but had difficulty sleeping. The following day (9/10), the area had extended to her forearm and because of the significant swelling, she had "no elbow". She experienced tingling in her fingers and thought that her left arm was weaker than her right; these symptoms resolved as the swelling diminished. She denies swollen or tender axillary lymph nodes. No red streaking of LUE. On 11/10, she was seen at ER and diagnosed as cellulitis; she was treated with 10-day course of Clindamycin. Symptoms began improving the next day and by 9/14, the area had decreased to about 3-4" and continued to gradually resolve. Itching persisted until 11/19. Pea-sized subcutaneous nodule remains. At peak of symptoms (9/10 and 9/11), she was limiting function due to pain - about 50% of normal function. She also reports experiencing significant fatigue following both anthrax vaccines, which has gradually improved and her energy level is now back to about 90% of baseline.